490 likes | 783 Views
WHO Definition Palliative Care. The active total care of patients whose disease is not responsive to curative treatment. Control of pain, of other symptoms, and of psychological, social and spiritual problems is paramount. The goal of palliative care is achievement of best quality of life for patien
E N D
1. Palliative Care Nikki Burger
GP Registrar
November 2005
2. WHO Definition Palliative Care The active total care of patients whose disease is not responsive to curative treatment. Control of pain, of other symptoms, and of psychological, social and spiritual problems is paramount. The goal of palliative care is achievement of best quality of life for patients and their families.
3. Components of Palliative Care Effective symptom control
Effective communication
Rehabilitation maximising independence
Continuity of care
Coordination of services
Terminal care
Support in bereavement
4. Funding Differs from the rest of the health service
20% inpatient units in UK funded entirely by NHS
Voluntary sector
Goodwill and fundraising initiatives in local communities
5. Funding National charities
Macmillan Cancer Relief
Marie Curie Cancer Care
Sue Ryder Foundation
These are the three major providers nationally.
6. Concept of Total Pain Physical pain
Anger
Depression
Anxiety
All affect patients perception of pain.
Needs thorough assessment
90% can be controlled with self-administered oral drugs
7. Depression Loss of social position
Loss of job prestige, income
Loss of role in family
Insomnia and chronic fatigue
Helplessness
Disfigurement
8. Anxiety Fear of hospital, nursing home
Fear of pain
Worry about family and finances
Fear of death
Spiritual unrest
Uncertainty in future
9. Anger Delays in diagnosis
Unavailable physicians
Uncommunicative physicians
Failure of therapy
Friends who dont visit
Bureaucratic bungling
10. Treatment options Analgesic drugs
Adjuvant drugs
Surgery
Radiotherapy
Chemotherapy
Spiritual and emotional support (total pain)
11. Analgesic drugs Mainstay of managing cancer pain
Choice based on severity of pain, not stage of disease
Standard doses, regular intervals, stepwise fashion
Non-opiod
weak opioid
strong opiod
+-adjuvant at any level (WHO analgesic ladder)
12. Non-opioid drugs Paracetamol
1g 4 hourly
NSAIDS
Ibuprofen 400mg 4 hourly
Aspirin 600mg 4 hourly
NB daily maximum doses
13. Weak opioids Codeine
60mg 4 hourly
Dihydrocodeine
30-80mg tds max 240mg daily
Dextropropoxyphene
65mg four hourly
Tramadol 50-100mg 6 hourly
Prescribing more than the maximum daily dose will increase s/e without producing further analgesia
14. Combinations Convenient
Care with dosing
Some combinations e.g co-codamol contain subtherapeutic doses of weak opioid
Co-proxamol only contains 325mg paracetamol
Get dosing right before moving on to strong opioids
15. Strong Opioids Morphine
Hydromorphone
Fentanyl
Diamorphine
Buprenorphine
16. Morphine Where possible dose by mouth
Dose tailored to requirements
Regular intervals prevent pain from returning
No arbitrary upper limit (unlike weak opioids)
Fears of patients and family
Side effects
17. Morphine Products Oramorph 4 hourly
Sevredol 4 hourly
Oramorph RS 12 hourly
Zomorph 12 hourly
MST 12 hourly
MXL 24 hourly
18. Starting Morphine - Dose titration Start with quick-release formulation
Prescribe regular four hourly dose, allow same size dose PRN in addition for breakthrough pain, as often as necessary
Usual starting dose 5-10mg four hourly
After 24-48 hours daily requirements can be calculated
19. Dose titration Once total dose required in 24 hours known, prescribe it as SR preparation (eg MST) bd
Provide additional doses of IR morphine (eg Oramorph) for breakthrough pain at 1/6 of total daily dose
If taking regular top-ups recalculate the total daily dose
20. Dose titration Example Mrs M
56y breast cancer with bony mets
Paracetamol 1g qds
Diclofenac SR 75mg bd
MST 60mg bd
Taking three doses Oramorph a day for breakthrough pain
What next?
21. Calculate total daily dose
60mg bd MST = 120mg
(120/6) x3 = 60mg
Total 180mg
22. So, prescribe
180/2 = MST 90mg bd
180/6 = Oramorph 30mg PRN for breakthrough pain.
23. Parenteral opiates Unable to maintain dosing by mouth
Subcutaneous infusion commonest alternative syringe driver
Convert oral dose to equianalgesic sc dose
Morphine /2
Diamorphine /3
Fentanyl patch
Less constipation, nausea, sedation
24. Opioid alternatives to morphine Hydromorphone
7 times more potent than morphine, so care in those with no prior exposure
25. Opioid alternatives to morphine Fentanyl
Self-adhesive patches
Changed every 72 hours
No IR form so for chronic stable pain, need IR morphine for breakthrough
24-48 hours for peak levels to be achieved
Useful if side effects with morphine
26. Oxycodone OxyContin
Onset 1 hour, 12 hour modified release
OxyNorm
Liquid and capsules
Immediate release
10mg oral oxycodone = 20mg oral morphine
27. Hydromorphone Palladone and Palladone SR
1.3mg hydromorphone = 10mg morphine
28. Writing a prescription for CDs By hand
In ink
Name and address patient
Name of drug
Form and strength
Total quantity, or number of dose units, in both words and figures
29. Writing a prescription for opiates Mary Jones
16 High Street, Worcester, WR1 1AA
Oramorph liquid 20mg/5ml
Supply 200ml (two hundred)
Take 20mg every 4 hours
Oramorph 10mg/5ml no longer a CD
30. Side effects of Opiates Common
Constipation
N+V
Sedation
Dry mouth Less common
Miosis
Itching
Euphoria
Hallucination
Myoclonus
Tolerance
Respiratory depression
31. Constipation Develops in almost all patients
Prescribe PROPHYLACTIC laxatives
Start with stimulant AND softener
Senna TT nocte PLUS
Docusate or lactulose
Also common with weak opioids
32. Nausea and vomiting Initially very common
Usually resolve over a few days
Easily controlled if forewarned
Metoclopramide 10mg 8 hourly
Haloperidol 1.5mg bd or nocte
33. Sedation Also common initially and then resolving
Be alert to possibility of recurrence of sedation or confusion after dose alteration
34. Dry mouth Often most troublesome symptom
Simple measures
Frequent sips cold drinks
Sucking boiled sweets
Ice cubes/frozen fruit segments
Eg pineapple or melon
35. Addiction Often feared by inexperienced prescribers and patients and families
Escalating requirements are sign of disease progression or possibly tolerance, not addiction
36. Opioid toxicity Wide variation in toxic doses between individuals and over time
Depends on
Degree of responsiveness
Prior exposure
Rate of titration
Concomitant medication
Renal function
37. Opioid toxicity Subtle agitation
Shadows at periphery of visual field
Vivid dreams
Visual hallucinations
Confusion
Myoclonic jerks
38. Agitated confusion Often misinterpreted as patient being in pain
Thus further opioids are prescribed
Vicious cycle, leads to dehydration
Accumulation of metabolites componds toxicity
Management
Reduce dose of opioid
Haloperidol 1.5-3mg SC/PO hourly as needed for agitation
Adequate hydration
39. Opioid responsiveness Not all pains respond well
Bone pain
Neuropathic pain
Need adjuvants
Drugs
Radiotherapy
Anaesthetic blocks
40. Common adjuvant analgesics NSAIDS
Corticosteroids
Antidepressant/-convulsants
Bisphosphonates Bone pain
Soft tissue inflitration
Hepatomegaly
Raised ICP
Soft tissue infiltration
Nerve compression
Hepatomegaly
Nerve compression
Nerve infiltration
Paraneoplastic neuropathy
Bone pain
41. Bone pain Paracetamol
Morphine
NSAIDS
Radiotherapy
Bisphosphonates
42. Neuropathic pain Features which suggest neuropathic pain
Burning
Shooting/stabbing
Tingling/pins and needles
Allodynia
Dysaesthesia
Dermatomal distribution
43. Neuropathic pain Antidepressant
Amitriptyline 50mg nocte
Anticonvulsant
Sodium Valproate 200mg bd (or Gabapentin or Carbamazepine)
Steroids
Dexamethasone 12mg daily
Antiarrhythmics
Mexiletine 50-300mg tds (or flecainide or lignocaine)
Anaesthetics
Ketamine
Nerve blocks and spinal anaesthesia
44. Neuropathic pain Complementary therapies
TENS
Acupuncture
Hypnosis
Aromatherapy
Counselling
Social support
45. Common mistakes in cancer pain management Forgetting there is more than one pain
Reluctance to prescribe morphine
Failure to use non-drug treatments
Failure to educate patient about treatment
Reducing interval instead of increasing dose
46. Any questions?
47. Reflective Learning Why?
Improve your insight into patients illness
Improve your relationship with patient or identify stumbling blocks
Improve your overall management of the whole patient
Identify gaps in knowledge
Fulfill the role of holistic practitioner offering care at end of life
48. Reflective Learning How has the diagnosis affected your relationship with the patient?
Do you feel uncomfortable in your attempts to communicate with the patient or family?
Have you explored the patients worries about their illness?
Have you explored their views on their treatment so far?
Do you feel that you have been of help?
Can you identify stages of anticipatory grief?
49. Other areas for future learning Breathlessness and cough
Mouth care/skin care/lymphoedema
N+V and intestinal obstruction
Anorexia, cachexia and nutrition
Constipation and diarrhoea
Non-cancer palliative care
Emergencies
Children
Caring for carers
Bereavement